NEW DATE to be announced shortly. Hosted by Arthur L. Irving Family Foundation, this symposium/workshop will focus on advancing the careers of young scientists in cancer immunology. Fifteen accomplished faculty mentors will share their research career experience in cancer immunology with ~40 promising young scientists (post-docs, advanced graduate students and starting faculty). Participants will learn how excellent science can be advanced by formulating questions, designing and executing studies to address these questions, hiring, mentoring, collaborating, leadership, raising funds, and publishing. Sessions will include lectures, small discussion/working groups with faculty mentors on specific topics, and review sessions to integrate lessons learned. Participants will also work on updating their research statement to support their next stage of career development. Applicants will be selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Applications are due by Feb 15, 2020 and participants will be informed of acceptance in March 2020.
Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 5-day program and extensive networking opportunities that CHI's IO Summit provides.
Oxford Global’s Immuno Series features 2 outstanding programmes consisting of key discussion topics in Immuno-Oncology, Autoimmunity, Immunology and Inflammation, enabling attendees to gain actionable insights into the approaches impacting this field from the leading immunotherapy experts.
Join the 5th Annual Advances in Immuno-Oncology Congress on 24-25 August and network with 350+ leaders at the forefront of research into the immune system. Connect with experts from pharma, biotech and academia working on the delivery of innovative immunotherapies.
The ESMO Congress is the most influential oncology platform in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world. ESMO Congress 2020 will present the very latest advances in oncology and translate science into better cancer patient care.
The ESMO Congress 2020 programme will be developed by a committee composed of more than 300 international experts under the leadership of Scientific Chair Prof John Haanen, NKI Amsterdam, Netherlands, a leading expert in the field of immunotherapy.
The Cancer Research Institute (CRI), the European Network for Cancer Immunotherapy (ENCI), and the American Association for Cancer Research (AACR) are proud to present the Sixth International Cancer lmmunotherapy Conference.
The 2020 meeting will be held at the New York Hilton Midtown in New York City from September 14-17, 2020. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.
This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.
NEW DATE: October 3-5, 2020
The 7th Immunotherapy of Cancer Conference (ITOC7) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.
NEW DATE: The 8th
Antibody Industrial Symposium AIS2020 jointly organized by the scientific society LabEx MAbImprove
and MabDesign, the French association of the Immunotherapy Industrial sector, will be held the 23 and 24 of November 2020 in Montpellier. This year edition will focus on a major theme chosen by the Scientific Advisory Board: “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”. It includes keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.
Moreover, the program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
ACIR readers get a 15% discount with the code ACIR15.
The focus of the IRCI symposium allows prominent scientists and clinicians to present their recent data in the multidisciplinary area of immunology in cancer and/or infectious diseases. As in our prior 1st IRCI symposium in 2017, our goal is to keep the number of participants limited thereby driving increased discussion between leaders in the field and attendees, thus strengthening as well as defining immunological research and curative therapies in the near future.
The IRCI meeting is organized by researchers from two leading centers in Lyon, the CIRI and CRCL. The first edition gathered more than 340 people from all around the world. This 2021 edition will highlight the recent discoveries in innate and adaptive immunity, immuno-metabolism; immunotherapy and (epi)genetics.